Page 85 - CIBEREHD2016-ENG

Most relevant scientific articles
• Villanueva C., Albillos A., Genesca J., Abraldes J.G., Calleja J.L., Aracil C. et al. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension. Hepatology. 2016;63(1):197-206.
• Conejo I., Augustin S., Pons M., Ventura-Cots M., Gonzalez A., Esteban R. et al. Alcohol consumption and risk of infection after a variceal bleeding in low-risk patients. Liver International. 2016.
• Nevens F., Andreone P., Mazzella G., Strasser S.I., Bowlus C., Invernizzi P. et al. A Placebo-controlled trial of obeticholic acid in primary biliary cholangitis. New England Journal of Medicine. 2016;375(7):631- 643.
• Ventura-Cots M., Concepcion M., Arranz J.A., Simon-Talero M., Torrens M., Blanco-Grau A. et al. Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients. Therapeutic Advances in Gastroenterology. 2016;9(6):823-835.
• Abraldes J.G., Bureau C., Stefanescu H., Augustin S., Ney M., Blasco H. et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study. Hepatology. 2016;64(6):2173-2184.
Hightlights
In 2016 the most relevant feature of our group is the substantial increase in clinical cooperative studies, both at the national and international level. It is worht to mention the participation of our group in an international clinical trial funded by the European Union.
EHD
research Groups 85